Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany

European Heart Journal

Volumn 19, Issue 8, 1998, Pages 1197-1207

  Keil, Ulrich ^a   Liese, A D ^a   Hense, H W ^a   Filipiak, B ^b   Doring A ^b   Stieber, J ^b   Lowel H ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Cohort study; Myocardial infarction; Population attributable fraction; Rate advancement period; Risk factors; Total mortality

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CORONARY RISK; FEMALE; GERMANY; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK; RISK FACTOR; SEX DIFFERENCE; SMOKING;

CAUSE OF DEATH; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; GERMANY; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SMOKING; SURVIVAL ANALYSIS;

EID: 0032147051     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1089     Document Type: Article

References (36)

1. [1] Keys A. Seven Countries. A Multivariate analysis of death and coronary heart disease. Cambridge, MA: Harvard University Press, 1980.
2. [2] Dawber TR. The Framingham Study. The epidemiology of atherosclerotic disease. Cambridge, MA: Harvard University Press, 1980.
3. [3] The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. J Chronic Dis 1978; 31: 201-306.
4. [4] Stamler J. Established major coronary risk factors. In: Marmot M, Elliott P, eds. Coronary heart disease epidemiology: from aetiology to public health. Oxford: Oxford Medical Publications; 1992: 35-66.
5. [5] Welin L, Eriksson H, Larsson B, Svärdsudd K, Wilhelmsen L, Tibblin G. Risk factors for coronary heart disease during 25 years of follow-up. The study of men born in 1913. Cardiology 1993; 82: 223-8.
6. [6] Håheim LL, Holme I, Hjermann I, Leren P. The predictability of risk factors with respect to incidence and mortality of myocardial infarction and total mortality. A 12-year follow-up of the Oslo Study, Norway. J Intern Med 1993; 234: 17-24.
7. [7] Keil JE, Sutherland SE, Hames CG et al. Coronary disease mortality and risk factors in black and white men. Results from the combined Charleston, SC, and Evans County, Georgia, heart studies. Arch Intern Med 1995; 155: 1521-7.
8. [8] Dagenais GR, Robitaille NM, Lupien PJ et al. First coronary heart disease event rates in relation to major risk factors: Quebec cardiovascular study. Can J Cardiol 1990; 6: 274-80.
9. [9] Cremer P, Muche R, Kruse-Lösler B, Seidel D, Labrot B. Myokardinfarktrisiko bei 40-bis 60jährigen Männern in Abhängigkeit von potentiellen Risikofaktoren der Atherosklerose. Zwischenauswertungen der Göttinger
10. Risiko-, Inzidenz-und Prävalenzstudie (GRIPS) nach einem 5jährigen Beobachtungszeitraum. Versicherungsmedizin 1989; 41: 154-62.
11. [10] Cremer P, Nagel D, Mann H et al. Ten-year follow-up results from the Göttingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men. Atherosclerosis 1997; 129: 221-30.
12. [11] Assmann G, Schulte H. Identification of individuals at high risk for myocardial infarction. Atherosclerosis 1994; 110 (Suppl): S11-21.
13. [12] Cullen P, Schulte H, Assmann G. The Münster Heart Study (PROCAM). Total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers. Circulation 1997; 96: 2128-36.
14. [13] Keil U, Koenig W, Löwel H et al. MONICA Project, Region Augsburg, Manual of Operations, Myocardial Infarction Register. GSF-Bericht 21, München: 1985.
15. [14] WHO MONICA Project. MONICA Manual. WHO Geneva, Cardiovascular Disease Unit, Geneva, 1990.
16. [15] Tunstall-Pedoe H for the WHO MONICA Project. The World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease): A Major International Collaboration. J Clin Epidemiol 1988; 41: 105-14.
17. [16] Keil U, Cairns V, Döring A et al. MONICA-Project, Region Augsburg, Manual of Operations, Survey. GSF-Bericht 20, München: 1985.
18. [17] Keil U, Stieber J, Döring A et al. The cardiovascular risk factor profile in the study area Augsburg: results of the first MONICA survey 1984/85. Acta Med Scand (Suppl) 1988; 728: 119-28.
19. [18] Löwel H, Lewis M, Hörmann A, Keil U. Case finding, data quality aspects and comparability of myocardial infarction registers: Results of a South German register study. J Clin Epidemiol 1991; 44: 249-60.
20. [19] Löwel H, Herman B, Lewis MA et al. Registration methods and estimates of morbidity and mortality of acute myocardial infarction: results from East and West Germany. Ann Epidemiol 1993; 3: S69-S78.
21. [20] Wright BM, Dore CF. The random zero-sphygmomanometer. Lancet 1970; i: 337-8.
22. [21] Kirkendall WM, Feinleib M, Freis ED. Recommendations for human blood pressure determination by sphygmomanometers. Hypertension 1981; 3: 510A-19A.
23. [22] Keil U, Chambless LE, Döring A, Filipiak B, Stieber J. The relation of alcohol intake to coronary heart disease and all-cause mortality in a beer-drinking population. Epidemiology 1997; 8: 150-6.
24. [23] Schaeffler V, Döring A, Winkler G, Keil U. Erhebung der Alkoholaufnahme: Vergleich verschiedener Methoden. Ernähr Umsch 1991; 38: 490-4.
25. [24] Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods, 2nd edn. Boston, MA: PWS-KENT Publishing Company, 1988.
26. [25] Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley and Sons, Inc; 1980.
27. [26] Wacholder S, Benichou J, Heineman EF, Hartge P, Hoover RN. Attributable risk: advantages of a broad definition of exposure. Am J Epidemiol 1994; 140: 303-9.
28. [27] Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research. New York, NY: Van Nostrand Reinhold, 1982.
29. [28] Brenner H, Gefeller O, Greenland S. Risk and rate advancement periods as measures of exposure impact on the occurrence of chronic diseases. Epidemiology 1993; 4: 229-36.
30. [29] Iribarren C, Reed DM, Burchfiel CM, Dwyer JH. Serum total cholesterol and mortality. Confounding factors and risk modification in Japanese-American men. JAMA 1995; 273: 1926-32.
31. [30] Norrish A, North D, Yee RL, Jackson R. Do cardiovascular disease risk factors predict all-cause mortality? Int J Epidemiol 1995; 24: 908-14.
32. [31] Davey Smith G. Low blood cholesterol and non atherosclerotic disease mortality: where do we stand? Eur Heart J 1997; 18: 6-9.
33. [32] Gaziano JM, Hebert PR, Hennekens CH. Cholesterol reduction: weighing the benefits and risks. Ann Intern Med 1996; 124: 914-18.
34. [33] Jousilahti P, Tuomilehto J, Vartiainen E et al. Importance of risk factor clustering in coronary heart disease mortality and incidence in eastern Finland. J Cardiovasc Risk 1995; 2: 63-70.
35. [34] EUROASPIRE study group. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J 1997; 18: 1569-82.
36. [35] Enbergs A, Liese A, Heimbach M et al. Sekundärprävention der koronaren Herzkrankheit auf dem Prüfstand. Ergebnisse der EUROASPIRE-Studie in der Region Münster. Z Kardiol 1997; 86: 284-91.